CDH1 and breast carcinoma: In human breast cancer, different authors associated E-cadherin decreased expression with worse prognosis, such as lower overall survival, disease-free interval, positive lymph node (Tang et al., 2012; Ricciardi et al., 2015; Wang et al., 2018), and higher proliferative rate evaluated by Ki-67 (Kashiwagi et al., 2011).